BioEdge 270 -- Wednesday, 17 October 2007

Home   |    Archives   |    Links   |    In the media
subscribe   |    subscribe my friend   |    to the editor   |    unsubscribe
BioEdge 270: Stem cell chief skids on banana peel

THIS WEEK


bullet 
Stem cell chief skids on banana peel
      New CIRM boss embarrassed by colleague's misconduct
bullet 
Stopping research cheats
      Not as easy as it seems
bullet 
DNA pioneer in hot water again
      Under fire for racist comments
bullet 
Lawsuit filed on behalf of embryo to derail CIRM
      Little hope of success
bullet 
Embryos have souls, says stem cell scientist
      And they shouldn't be misused
bullet 
Reprogramming is the future, says Gearhart
      But embryo experiments still needed
bullet 
Nobel awarded for work with embryonic stem cells
      Tales of knock-out mice
bullet 
Suicide as a tidy little earner
      Japanese man accused of selling suicide goods over internet
bullet 
Selling the "mom job"
      By pathologising women's bodies
bullet 
The next big thing after artificial intelligence
      "Intimate relationships" with robots
bullet 
Footnotes
      Illinois, Florida

Stem cell chief skids on banana peel

Professor Alan Trounson The newly-appointed head of the world's biggest stem cell program, the California Institute for Regenerative Medicine, IVF scientist Alan Trounson, has been embarrassed by irregularities in a research program which he had been supervising at Monash University, in Melbourne, Australia.

An adult stem cell project which he was supervising has been scrapped after an audit in November last year found that a scientist's progress reports did not match his lab records. Although Professor Trounson is not under investigation -- it must be stressed -- he was the principal investigator and apparently did sign the doubtful report.

The researcher in question has left the university. He was a senior member of a team working on a lung regeneration project which was attempting to use adult mesenchymal stem cells to regenerate lung tissue to treat cystic fibrosis. It had received A$1.2 million funding over 18 months from the Australian Stem Cell Centre.

The news did not shake the confidence of the CIRM. "I am fully aware of this and it is not Alan's work that is being questioned," Robert Klein, CIRM founder and chairman, told The Australian. "My understanding is that this is a data issue that relates to the science carried out by a specific researcher." He said that Professor Trounson had raised the issue in discussions with the CIRM before his appointment. ~ Australian, Oct 15; The Scientist, Oct 17   

Stopping research cheats

With high-profile scandals like the reports fabricated by stem cell scientist Hwang Woo-suk in mind, everyone is concerned with a growing incidence of scientific misconduct. But how to stop it is puzzling. The first world conference on research integrity, held in Lisbon in September, presented a daunting picture. While out-and-out fraud seems to be rare, pushing the envelope has become easier.

"People sort of touching up their gels -- things like that are a lot easier now than it used to be," Tim Hunt of Cancer Research UK told the journal Cell. "There's a bell curve with absolutely exemplary practice at one end and misconduct at the other and a big bell in the middle representing degrees of questionable practice. How do we address that? How do we ensure that people don't slide down one side of the bell into the misconduct side?"

One response to the problem is increased ethical training for young scientists. But a study by Melissa Anderson, of the University of Minnesota, suggests that this could sometimes be worse than useless. Formal instruction, it turns out, significantly increases the odds of poor choices when collecting and analysing data, dealing with confidential information or allowing inappropriate influence by funding organisations. It is also correlated with a higher probability of not giving proper credit to others.

How about mentoring? Mentoring in research and ethics decreases the likelihood of misconduct, but advice on how to survive in the field and use funds actually increases it. Of the younger scientists in Dr Anderson's survey, biologists were among the least likely to be mentored in ethics -- they received more advice about getting funding.

Whatever the reason, scientists carry the ethical standards they learned elsewhere into their labs. "Surveys consistently show that the incidence of cheating in high school and college is very high, well over 50%, and it's unreasonable to expect that these people who were cheating in college will never cheat again," David Resnik, a bioethicist at the National Institute of Environmental Health Sciences, in North Carolina, told Cell. "It's not surprising that you find fraud in science -- scientists are people too - but we tend to hold scientists up on a pedestal." ~ Nature, Oct 11; Cell, Oct 5; Academic Medicine, Sept   

DNA pioneer in hot water again

James Watson, 1962 Nobel laureate for discovering the structure of DNA, has kindled a huge controversy in the UK by making apparently racist remarks in the course of a PR tour for his memoirs. The Science Museum in London has cancelled a sell-out appearance by Watson. It claims that he had gone "beyond the point of acceptable debate" by claiming that black people were less intelligent than white people.

Watson is no stranger to controversy. He is well-known for supporting selective abortions, denigrating a female colleague whose work helped him to win his Nobel, sexist remarks, contempt for "stupid people", support for human reproductive cloning, backing genetic engineering, and so. This time, however, he touched a particularly raw nerve.

A long interview with the Sunday Times included this unnerving paragraph: "He says that he is 'inherently gloomy about the prospect of Africa' because 'all our social policies are based on the fact that their intelligence is the same as ours ­ whereas all the testing says not really', and I know that this 'hot potato' is going to be difficult to address. His hope is that everyone is equal, but he counters that 'people who have to deal with black employees find this not true'."

Watson will be touring the UK to promote his new book Avoid Boring People: And Other Lessons from a Life in Science. At least he is following his own advice. ~ Sunday Times, Oct 14; Independent, Oct 18   

Lawsuit filed on behalf of embryo to derail CIRM

Mary Scott Doe, an unborn embryo, is suing the chairman of the California Institute of Regenerative Medicine. The lawsuit, brought by Maryland lawyer Martin Palmer, is intended to derail the CIRM's work. It challenges embryonic stem cell research by alleging that the destruction of human embryos violates the 13th Amendment to the US Constitution, which guarantees equal protection under the law, and the 14th Amendment, which bans slavery.

A spokesman for the CIRM called the suit "specious". "Our assumption," he said, "is that someone like this is going to be suing CIRM from now until the project ends. It's just going to become a routine cost of doing business for us. But we believe we're on absolute rock solid legal ground." ~ Wired, Oct 12   

Embryos have souls, says stem cell scientist

Markus Grompe A leading US stem cell scientist has declared that embryos are human and have a human soul from the beginning of their existence. Writing in Nature Reports Stem Cells, Markus Grompe, the director of the Oregon Stem Cell Center, in Oregon, says that this implies that "they have a special moral status and should not be destroyed for any reason, even for the creation of [embryonic stem] cell lines".

Dr Grompe acknowledges that his position places him in a dilemma. "I have found myself in a conflict between my philosophical convictions on the one hand and the desire to exploit pluripotent stem cells for research and clinical applications on the other. I have also found myself in the cross fire in the public debate between the pro-ES cell and anti-ES cell camps."

Dr Grompe's qualms are not religious, but philosophical in the Aristotelian tradition. The soul, he says, is "the unifying principle of its formation or organisation". The concept expresses the idea that "something more than the material from which it is constructed governs the nature of a being".

To negotiate a way forward, he supports alternative methods for producing pluripotent human stem cells which are nearly identical to embryo-derived stem cells. One such method is directly reprogramming adult cells back to a pluripotent state. This has already been proven in mice, but Dr Grompe feels that there are serious problems with reprogramming human cells at the moment. Another is altered nuclear transfer. This has been ridiculed by many scientists, but Dr Grompe feels that it could be "a powerful experimental system for studying reprogramming factors".

Both sides of the stem cell debate have been guilty of "half-truths, exaggeration and outright disinformation", he says. The pro-ES cell side has engaged in "public campaigns that have twisted scientific fact in sometimes grotesque ways". The anti-ES cell side has touted the virtues of adult stem cells unrealistically.

"The truth is that the potential of ES cells for curing human diseases is unknown. It is therefore factually wrong to state that limitations on ES cell research are preventing life-saving cures, and it is equally false to claim that ES cells have no therapeutic potential. At this point, we simply don't know - and without the appropriate research, we will never know." ~ Nature Reports Stem Cells, Oct 11   

Reprogramming is the future, says Gearhart

In a similar vein, one of the best-known American stem cell scientists, John Gearhart, of Johns Hopkins University, in Baltimore, writes in the New England Journal of Medicine that "reprogramming of adult cells to generate patient-specific therapies represents the future for stem-cell biologists." However, unlike Grompe, he insists that research on embryos must proceed. "Such cells remain the gold standard for determining the molecular basis of human tissue development and for developing cell-based therapies for human diseases." ~ New England Journal of Medicine, Oct 11   

Nobel awarded for work with embryonic stem cells

This year's Nobel awards for medicine highlight the growing possibilities of genetically-enhanced humans. Mario Capecchi, of the University of Utah, Martin Evans, of Cardiff University in Wales, and Oliver Smithies, of the University of North Carolina at Chapel Hill, have shared the US$1.5 million prize for their work in developing knock-out mice.

For non-scientists, the term "knock-out mice" may sound cartoonish, but it is an immensely powerful technology which is being applied to virtually all areas of biomedicine -- from basic research to the development of new therapies. Using techniques developed by Capecchi and Smithies, scientists can disable, or knock-out, specific genes. This helps scientists to establish what these genes do.

Martin Evans's contribution was to use mouse embryonic stem cells to create strains of mice which inherit an altered genome. They have become commonplace in studies of embryonic development, adult physiology, ageing and disease. To date, more than 10,000 mouse genes -- about half the genome -- have been knocked out. Scientists expect that the whole genome will soon be mapped.

These discoveries are already having an impact upon the study of genetic diseases, such cystic fibrosis, thalassemia, hypertension and atherosclerosis. They also make it possible to consider altering the human genome, although this is only part of the transhumanist utopia at the moment. ~ Nature, Oct 11   

Suicide as a tidy little earner

A Japanese man deep in debt has been arrested after making assisted suicide into a money-spinner. Kazunari Saito, 33, will probably be charged with murder-by-contract, which is punishable with seven years in jail. Police allege that a woman paid him ¥200,000 to kill her by administering a huge dose of sleeping pills and then suffocating her with a plastic bag. Mr Saito set up a suicide web site to make money because he owed ¥6 million to various moneylenders, said police. By selling sleeping pills over the internet, he had managed to earn about ¥1 million. ~ Japan Times, Oct 13   

Selling the "mom job"

Despite protests from doctors and feminists, "mommy makeovers" -- breast augmentation, tummy tucks, and liposuction -- are becoming more and more popular in the US to help women regain an hourglass figure after child bearing. Last year more than 325,000 women between 20 and 39 had "mom jobs", up 11% from 2005. Plastic surgeon William H. Huffaker told the New York Times that he operates on three or four mothers a week at a cost of between US$12,000 to $15,000.

According to the Times, advertising for mom jobs "seeks to pathologise the postpartum body, characterising pregnancy and childbirth as maladies with disfiguring after-effects that can be repaired with the help of scalpels and cannulae."

Other factors are at work, too, which impel women to seek surgical help. There is more pressure to look young and sexy today, said one woman who had recently remarried. "I don't think it was an issue for my mother; your husband loved you no matter what," she said. ~ New York Times, Oct 4   

The next big thing after artificial intelligence

Robots will become so much like people in the future that we could fall in love with them, have sex with them, and even marry them, according to a British expert in artificial intelligence. David Levy has just finished a doctorate at the University of Maastricht entitled "Intimate relationships with artificial partners". His book, Love and Sex with Robots, will be published in November by HarperCollins.

Mr Levy bases his forecast on current trends in robotics and artificial intelligence. Virtual pets like the popular Tamagotchi foreshadow human emotions towards robots. Emotions, he believes, can be computerised so that robots can detect them in human and respond to them.

"Once the reader has accepted this notion, it is only a short mental step to the concept of humans feeling emotions for robots, together with all that implies, including fears such as: 'I think my wife is having an affair with her hairdresser robot'," says Mr Levy. ~ Daily Mail, Oct 12   

Footnotes

ILLINOIS: The giant US retailer Walgreens has reached a settlement with the state of Illinois which will allow its pharmacists to refuse to dispense the morning-after pill. Illinois requires pharmacists to fill all prescriptions even if they have ethical objections. Under the settlement, trained technicians or store owners would contact a pharmacist at another location and then follow his instructions to dispense the pill. ~ Washington Post/AP, Oct 11

FLORIDA SURROGACY: A husband and wife from Florida have lost a court battle for custody of a child whom they commissioned from a surrogate mother. Tom and Gwyn Lamitina found Stephanie Eckard, a two-time surrogate, on the internet. They supplied her with sperm, but after she became pregnant, the deal went sour. Under Florida law, the judge ruled, Mr Lamitina is merely a sperm donor, not a father. ~ Orlando Sentinel, Oct 11   

  

How to support BioEdge
BioEdge and ABI's other services rely completely upon the generosity of private benefactors and volunteer workers. ABI has no institutional backing. If you would like to support the best bioethics news service on the Web, you can do it painlessly through Paymate, a thoroughly reliable payment service which is affiliated with the internet auction site eBay.

Just access the Paymate website and follow the instructions. You will need to fill in our email address, which is bioedge@australasianbioethics.org. You will also have to give your credit card details and an amount in Australian or US dollars. Thanks!

  

 

To subscribe to our weekly email newsletter,
click here for the HTML version.
click here for the text version.
To cancel your newsletter subscription, click here.

Australasian Bioethics Information
ISSN 1446-2117
Website:www.australasianbioethics.org
BioEdge editor: Michael Cook
New Zealand Contributing Editor: Carolyn Moynihan


The BioEdge privacy policy
Your subscription information will be kept private and is not publicly accessible.
Your email address and other information will never be sold to a third party or given out
without your consent. You may cancel your subscription at any time.